Memorial Hospital INC
Memorial Hospital INC was paid $4.01M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 20% of everything it billed.
NEILLSVILLE, WI 54456
Next to other Critical Access Hospital providers in Wisconsin
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,858 | $334K | |
| 2019 | 8,926 | $354K | |
| 2020 | 9,359 | $386K | |
| 2021 | 14,461 | $618K | |
| 2022 | 13,955 | $790K | |
| 2023 | 16,597 | $852K | |
| 2024incomplete | 13,912 | $678K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 20% | 1,784 | 1,133 | $812K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 3,164 | 2,221 | $564K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 4,420 | 3,679 | $456K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 2,852 | 2,380 | $430K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.8% | 1,957 | 1,519 | $393K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.9% | 1,344 | 923 | $237K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 992 | 862 | $135K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.9% | 1,521 | 1,312 | $114K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.7% | 329 | 279 | $110K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 271 | 220 | $80K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | 1.9% | 680 | 528 | $75K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.1% | 692 | 575 | $45K |
88 more codes
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,393 | $40K |
| G0382 | Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 471 | $39K |
| 80053 | Comprehensive metabolic panel | <1% | 5,517 | $39K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,806 | $33K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 123 | $29K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 176 | $28K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 655 | $27K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,295 | $25K |
| 80061 | Lipid panel | <1% | 2,159 | $22K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,757 | $22K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,851 | $21K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,548 | $20K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 300 | $19K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 104 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,867 | $17K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 679 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,696 | $12K |
| 84484 | <1% | 1,997 | $10K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 909 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,143 | $8K |
| 81001 | <1% | 3,542 | $8K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 63 | $8K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 53 | $6K |
| 80050 | General health panel | <1% | 522 | $6K |
| 82728 | <1% | 474 | $6K | |
| 87634 | <1% | 149 | $6K | |
| 83690 | <1% | 1,276 | $6K | |
| 81025 | <1% | 594 | $4K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 157 | $4K |
| 85027 | <1% | 850 | $4K | |
| 85610 | <1% | 1,372 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 553 | $3K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 37 | $3K |
| 87631 | <1% | 27 | $3K | |
| 83605 | <1% | 543 | $3K | |
| 83880 | <1% | 136 | $2K | |
| 83735 | <1% | 643 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,012 | $2K |
| 84153 | <1% | 147 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,573 | $2K |
| 86803 | <1% | 176 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,684 | $2K |
| 86140 | <1% | 653 | $2K | |
| 84439 | <1% | 252 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 141 | $2K |
| 73562 | <1% | 16 | $1K | |
| 85379 | <1% | 237 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 359 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 18 | $860.54 |
| 83550 | <1% | 109 | $830.29 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 803 | $763.13 |
| 73030 | <1% | 17 | $748.00 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 50 | $695.85 |
| 97035 | <1% | 203 | $660.33 | |
| 83655 | <1% | 46 | $535.89 | |
| 82150 | <1% | 113 | $524.14 | |
| 83540 | <1% | 80 | $487.99 | |
| 97161 | <1% | 25 | $487.01 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $486.12 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | $463.33 |
| 85652 | <1% | 209 | $407.34 | |
| 87040 | <1% | 134 | $389.51 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 25 | $388.13 |
| 81003 | <1% | 132 | $313.20 | |
| 82570 | <1% | 63 | $306.04 | |
| 88142 | <1% | 17 | $267.16 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 990 | $258.35 |
| 84145 | <1% | 31 | $255.70 | |
| 84702 | <1% | 19 | $254.76 | |
| 82043 | <1% | 43 | $245.64 | |
| 80306 | <1% | 20 | $202.28 | |
| 82550 | <1% | 81 | $201.62 | |
| 96376 | <1% | 30 | $197.09 | |
| 85018 | <1% | 79 | $160.85 | |
| 82962 | <1% | 78 | $137.48 | |
| 36592 | <1% | 355 | $116.49 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 173 | $84.85 |
| 85730 | <1% | 33 | $80.16 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,484 | $15.45 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 894 | $9.53 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 484 | $6.96 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 200 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 28 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 17 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 63 | $0.00 |
| A9270 | Non-covered item or service | 0% | 172 | $0.00 |
| 3044F | 0% | 13 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Lakeview Medical Center INC of Rice Lake | Rice Lake, WI | $9.98M |
| Flambeau Hospital INC | Park Falls, WI | $6.99M |
| Lakeview Medical Center INC of Rice Lake | Rice Lake, WI | $2.24M |
| Lakeview Medical Center INC of Rice Lake | Rice Lake, WI | $1.64M |
| MCHS Hospitals INC | Stevens Point, WI | $906K |
| Dickinson County Healthcare System | Iron Mountain, MI | $564K |
| Memorial Hospital INC | Colby, WI | $477K |
| Memorial Hospital INC | Neillsville, WI | $457K |
| Flambeau Hospital INC | Park Falls, WI | $421K |
| Dickinson County Healthcare System | Marquette, MI | $108K |
| MCHS Hospitals INC | Stevens Point, WI | $100K |
| Flambeau Hospital INC | Phillips, WI | $85K |
| Lakeview Medical Center INC of Rice Lake | Hayward, WI | $62K |
| MCHS Hospitals, INC. | Plover, WI | $60K |
| Lakeview Medical Center INC of Rice Lake | Cumberland, WI | $49K |
| Memorial Hospital INC | Greenwood, WI | $26K |
| Marshfield Clinic INC | Marshfield, WI | $9K |
| MCHS Hospitals INC | Chippewa Falls, WI | $5K |
| MCHS Hospitals INC | Wausau, WI | $5K |
| Memorial Hospital INC | Stratford, WI | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.